Status:

COMPLETED

First Study With a Brain Implant to Help Locked-in Patients Communicate at Home

Lead Sponsor:

UMC Utrecht

Conditions:

Locked-In Syndrome

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

In this study a new means of communication for people with locked-in syndrome will be tested. The investigators will record brain signals directly from the surface of the brain by means of a completel...

Detailed Description

In this pilot study we will provide locked-in people with a new means of communication which has not been possible up to now. For the first time, we will test whether we can record and decode neural s...

Eligibility Criteria

Inclusion

  • Age 18 - 75
  • Locked-in status (i.e. severely paralyzed with communication problems)
  • in case of trauma or stroke: at least 1 year after the event
  • in case of a neuromuscular disease: slow progression allowed
  • Rudimentary form of communication possible (e.g. through assistive technology, eye blinks or eye movements, severely impaired speech)
  • Mentally and physically capable of giving informed consent
  • Lives in or close to the Netherlands
  • MR compatible
  • able to lie flat in the scanner
  • no metal objects in or attached to the body
  • no claustrophobia
  • Visus (largely) intact
  • Cognition intact (IQ\>80)
  • Compatible with implantation procedure
  • good respiratory function or stable respiratory situation using ventilation assistance

Exclusion

  • Strong and frequent spasms
  • Vital indication for blood thinners
  • Current brain tumor or history of tumor resection
  • Quick medical or neurological deterioration
  • Patients who are considered legally incapable (and who therefore will not be able to give informed consent)
  • Current or recent psychiatric disorder
  • Catabolic state
  • Allergy to the materials of the implant

Key Trial Info

Start Date :

September 9 2015

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 14 2024

Estimated Enrollment :

6 Patients enrolled

Trial Details

Trial ID

NCT02224469

Start Date

September 9 2015

End Date

February 14 2024

Last Update

December 3 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Medical Center

Utrecht, Netherlands, 3584CX